About Brian Blagg
Form D filings for Grannus Therapeutics from 2022 to 2024 list Brian Blagg as director.
Brian Blagg first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Brian Blagg in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Brian Blagg works with at each company, as listed on that company's latest Form D.
Grannus Therapeutics, Inc. · Form D, Jan 12, 2024
JF
John Foglesong
CEO and director